KalVista Pharmaceuticals ... (KALV)

AI Score

Unlock

10.16

-1.16 (-10.25%)

At close: Apr 04, 2025, 10:58 AM

KalVista Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017	Apr 30, 2016	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	31.79M	56.24M	30.73M	50.59M	15.79M	32.01M	51.05M	30.95M	21.76M	3.9M	9.78M	8.24M
Short-Term Investments	178.61M	93.14M	135.47M	198.34M	51.92M	68.81M	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	199K	n/a	n/a	n/a
Other Long-Term Assets	567K	106K	193K	200K	178K	173K	173K	n/a	-199K	1.88M	120K	120K
Receivables	10.87M	16.57M	n/a	10.42M	16.53M	11.31M	6.83M	2.55M	356K	n/a	n/a	n/a
Inventory	n/a	n/a	2.71M	n/a	n/a	n/a	n/a	n/a	n/a	-235.41	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	225.69M	172.33M	193.65M	264.26M	88.7M	115.55M	59.38M	34.25M	24.67M	4.59M	9.91M	8.32M
Property-Plant & Equipment	9.15M	10.77M	10.04M	7.55M	3.65M	2.41M	1.84M	97K	74K	180K	75K	84K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	9.71M	10.88M	10.23M	7.75M	3.83M	2.59M	2.01M	97K	74K	2.06M	195K	204K
Total Assets	235.4M	183.2M	203.88M	272.01M	92.53M	118.13M	61.39M	34.34M	24.75M	6.64M	10.11M	8.53M
Account Payables	9.11M	4.82M	3.64M	1.98M	1.68M	2.86M	1.43M	1.15M	1.01M	1.02M	462K	147K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	9.54M	18.48M	n/a	29K	29K	29K	23K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.43M	3.06M	2.69M
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.49M	882K	195K	96K
Total Current Liabilities	22.81M	15.03M	11.58M	9.77M	7.72M	18.05M	23.22M	3.02M	3.25M	7.09M	3.95M	3.07M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.13M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-56K	38.24M	39.75M	33.63M
Total Long-Term Liabilities	6.01M	7.14M	7.21M	5.05M	1.06M	3.34M	10.92M	1.15M	1.01M	43.73M	39.86M	33.75M
Total Liabilities	28.82M	22.18M	18.79M	14.82M	8.78M	21.39M	34.14M	3.02M	3.25M	50.83M	43.81M	36.81M
Total Debt	7.32M	8.23M	8.19M	5.91M	1.65M	54K	279K	n/a	4.61M	6.57M	3.06M	2.69M
Common Stock	42K	34K	25K	24K	18K	17K	11K	10K	3K	1K	2K	2K
Retained Earnings	-469.73M	-343.08M	-250.18M	-167.84M	-121.59M	-92.48M	-71.66M	-55.85M	-37.25M	-47.77M	-34.42M	-28.74M
Comprehensive Income	-3.49M	-3.06M	-3.86M	-1.43M	-1.88M	-1.93M	-1.11M	-2.64M	-75K	-495K	-441K	-414K
Shareholders Equity	206.58M	161.03M	185.09M	257.19M	83.75M	96.74M	27.25M	31.33M	21.5M	-44.18M	-33.71M	-28.29M
Total Investments	178.61M	93.14M	135.47M	198.34M	51.92M	68.81M	n/a	n/a	199K	n/a	n/a	n/a